Davidson Capital Management’s AbbVie ABBV Stock Holding History

Davidson Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54	Closed	-$8.37K	–	95
2023 Q4	$8.37K	Buy	+54	New	+$7.87K	﹤0.01%	73
2023 Q2	–	Sell	-9,664	Closed	-$1.54M	–	84
2023 Q1	$1.54M	Sell	9,664 -44	-0.5%	-$6.73K	0.94%	15
2022 Q4	$1.57M	Sell	9,708 -34	-0.3%	-$5.21K	1.08%	11
2022 Q3	$1.31M	Buy	9,742 +745	+8%	+$107K	0.64%	18
2022 Q2	$1.38M	Sell	8,997 -23	-0.3%	-$3.52K	0.65%	11
2022 Q1	$1.46M	Sell	9,020 -2,558	-22%	-$372K	0.55%	23
2021 Q4	$1.57M	Buy	11,578 +371	+3%	+$43.8K	0.86%	21
2021 Q3	$1.21M	Buy	11,207 +398	+4%	+$45.5K	0.61%	53
2021 Q2	$1.22M	Buy	10,809 +103	+1%	+$11.6K	0.59%	53
2021 Q1	$1.16M	Buy	+10,706	New	+$1.15M	0.61%	44

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Davidson Capital Management's ABBV Position: Q1 2024 in Review

Davidson Capital Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 54 shares — an estimated $8.37K sold.

Davidson Capital Management first reported a position in ABBV in Q1 2021 and held it in 10 quarters. The position peaked at $1.57M in Q4 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Davidson Capital Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
Davidson Capital Management sold 54 AbbVie shares in Q1 2024, an estimated $8.37K.
Davidson Capital Management first reported a position in AbbVie in Q1 2021 and held it in 10 quarters.
Davidson Capital Management's AbbVie position peaked at $1.57M in Q4 2022.
3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Davidson Capital Management's 13F filing for Q1 2024, filed 6 May 2024.